Filtered By:
Countries: Netherlands Health

This page shows you your search results in order of date. This is page number 11.

Order by Relevance | Date

Total 370 results found since Jan 2013.

Clinical consequences of consecutive self-expanding transcatheter heart valve iterations
CONCLUSIONS: TAVI with self-expanding valves was safe, and device iterations may result in a lower need for PPI. More-than-mild PVL seemed to occur less often with repositionable technology.PMID:33914259 | DOI:10.1007/s12471-021-01568-5
Source: Netherlands Heart Journal - April 29, 2021 Category: Cardiology Authors: H G Kroon L van Gils F Ziviello M P H van Wiechen J F W Ooms Z Rahhab N El Faquir A-M Maugenest J A Goudzwaard P Cummins M Lenzen I Kardys J Daemen F Mattace-Raso P P T de Jaegere N M Van Mieghem Source Type: research

Detection of asymptomatic carotid stenosis in patients with lower-extremity arterial disease: development and external validations of a risk score
CONCLUSION: The present risk score can predict significant ACS in patients with LEAD. This approach may inform targeted screening of high-risk individuals to enhance the detection of ACS.PMID:33876207 | DOI:10.1093/bjs/znab040
Source: The British Journal of Surgery - April 20, 2021 Category: Surgery Authors: Michiel H F Poorthuis Dylan R Morris Gert J de Borst Michiel L Bots Jacoba P Greving Frank L J Visseren Paul Sherliker Rachel Clack Robert Clarke Sara Lewington Richard Bulbulia Alison Halliday Source Type: research

Effect of anticoagulant therapy in COVID-19 patients
CONCLUSION: Analysis of the literature showed that there was insufficient evidence to answer our objective on the effect of anticoagulation on outcome in COVID-19 patients, especially due to the low scientific quality of the described studies. Randomised controlled studies are needed to answer this question.PMID:33861430 | DOI:10.1007/s12471-021-01574-7
Source: Netherlands Heart Journal - April 16, 2021 Category: Cardiology Authors: R G Tieleman F A Klok E Belfroid J Hoogervorst-Schilp I Schalkers C W Jansen H J Siebelink Source Type: research

The effects of ACE2 expression mediating pharmacotherapy in COVID-19  patients
CONCLUSION: Analysis of the literature demonstrated that there was insufficient evidence to answer our objective on the effect of ACE2 expression mediating pharmacotherapy on outcome in COVID-19 patients, especially due to the low scientific quality of the described studies. Randomised controlled studies are needed to answer this question.PMID:33860910 | DOI:10.1007/s12471-021-01573-8
Source: Netherlands Heart Journal - April 16, 2021 Category: Cardiology Authors: R R J van Kimmenade E Belfroid J Hoogervorst-Schilp H J Siebelink C W Janssen Y Pinto Source Type: research

Effect of anticoagulant therapy in COVID-19 patients
CONCLUSION: Analysis of the literature showed that there was insufficient evidence to answer our objective on the effect of anticoagulation on outcome in COVID-19 patients, especially due to the low scientific quality of the described studies. Randomised controlled studies are needed to answer this question.PMID:33861430 | PMC:PMC8050812 | DOI:10.1007/s12471-021-01574-7
Source: Netherlands Heart Journal - April 16, 2021 Category: Cardiology Authors: R G Tieleman F A Klok E Belfroid J Hoogervorst-Schilp I Schalkers C W Jansen H J Siebelink Source Type: research

The effects of ACE2 expression mediating pharmacotherapy in COVID-19  patients
CONCLUSION: Analysis of the literature demonstrated that there was insufficient evidence to answer our objective on the effect of ACE2 expression mediating pharmacotherapy on outcome in COVID-19 patients, especially due to the low scientific quality of the described studies. Randomised controlled studies are needed to answer this question.PMID:33860910 | PMC:PMC8050813 | DOI:10.1007/s12471-021-01573-8
Source: Netherlands Heart Journal - April 16, 2021 Category: Cardiology Authors: R R J van Kimmenade E Belfroid J Hoogervorst-Schilp H J Siebelink C W Janssen Y Pinto Source Type: research

Effect of anticoagulant therapy in COVID-19 patients
CONCLUSION: Analysis of the literature showed that there was insufficient evidence to answer our objective on the effect of anticoagulation on outcome in COVID-19 patients, especially due to the low scientific quality of the described studies. Randomised controlled studies are needed to answer this question.PMID:33861430 | PMC:PMC8050812 | DOI:10.1007/s12471-021-01574-7
Source: Netherlands Heart Journal - April 16, 2021 Category: Cardiology Authors: R G Tieleman F A Klok E Belfroid J Hoogervorst-Schilp I Schalkers C W Jansen H J Siebelink Source Type: research

The effects of ACE2 expression mediating pharmacotherapy in COVID-19  patients
CONCLUSION: Analysis of the literature demonstrated that there was insufficient evidence to answer our objective on the effect of ACE2 expression mediating pharmacotherapy on outcome in COVID-19 patients, especially due to the low scientific quality of the described studies. Randomised controlled studies are needed to answer this question.PMID:33860910 | PMC:PMC8050813 | DOI:10.1007/s12471-021-01573-8
Source: Netherlands Heart Journal - April 16, 2021 Category: Cardiology Authors: R R J van Kimmenade E Belfroid J Hoogervorst-Schilp H J Siebelink C W Janssen Y Pinto Source Type: research

Effect of anticoagulant therapy in COVID-19 patients
CONCLUSION: Analysis of the literature showed that there was insufficient evidence to answer our objective on the effect of anticoagulation on outcome in COVID-19 patients, especially due to the low scientific quality of the described studies. Randomised controlled studies are needed to answer this question.PMID:33861430 | PMC:PMC8050812 | DOI:10.1007/s12471-021-01574-7
Source: Netherlands Heart Journal - April 16, 2021 Category: Cardiology Authors: R G Tieleman F A Klok E Belfroid J Hoogervorst-Schilp I Schalkers C W Jansen H J Siebelink Source Type: research

The effects of ACE2 expression mediating pharmacotherapy in COVID-19  patients
CONCLUSION: Analysis of the literature demonstrated that there was insufficient evidence to answer our objective on the effect of ACE2 expression mediating pharmacotherapy on outcome in COVID-19 patients, especially due to the low scientific quality of the described studies. Randomised controlled studies are needed to answer this question.PMID:33860910 | PMC:PMC8050813 | DOI:10.1007/s12471-021-01573-8
Source: Netherlands Heart Journal - April 16, 2021 Category: Cardiology Authors: R R J van Kimmenade E Belfroid J Hoogervorst-Schilp H J Siebelink C W Janssen Y Pinto Source Type: research

Dairy consumption and mortality after myocardial infarction: a prospective analysis in the Alpha Omega Cohort
CONCLUSIONS: In Dutch post-MI patients, yogurt consumption was inversely associated with CVD mortality and all-cause mortality. Associations for milk and other dairy products were neutral or inconsistent.This trial was registered at clinicaltrials.gov as NCT03192410.PMID:33826695 | DOI:10.1093/ajcn/nqab026
Source: Am J Clin Nutr - April 7, 2021 Category: Nutrition Authors: Esther Cruijsen Maria G Jacobo Cejudo Leanne K K üpers Maria C Busstra Johanna M Geleijnse Source Type: research